Arrowhead Pharmaceuticals, Inc. (FRA:HDP1)

Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	7,542	4,064	2,159	2,721	3,568	5,616
Market Cap Growth	219.06%	88.24%	-20.66%	-23.72%	-36.47%	49.72%
Enterprise Value	7,425	3,904	2,184	2,644	3,246	5,191
Last Close Price	55.38	28.97	17.46	25.31	33.60	52.20
PS Ratio	10.67	5.75	678.12	11.96	14.38	47.07
PB Ratio	17.58	9.47	12.60	10.03	8.36	15.92
P/TBV Ratio	19.27	10.39	13.61	11.03	9.05	16.47
P/FCF Ratio	56.40	30.40	-	-	-	44.06
P/OCF Ratio	49.28	26.56	-	-	-	37.99
EV/Sales Ratio	10.41	5.52	686.02	11.63	13.09	43.51
EV/EBITDA Ratio	62.23	37.47	-	-	-	-
EV/EBIT Ratio	87.82	46.58	-	-	-	-
EV/FCF Ratio	55.53	29.20	-	-	-	40.72
Debt / Equity Ratio	1.46	1.46	4.46	1.34	0.20	0.06
Debt / EBITDA Ratio	5.29	5.29	-	-	-	-
Debt / FCF Ratio	4.68	4.68	-	-	-	0.17
Asset Turnover	0.66	0.66	0.00	0.33	0.35	0.22
Quick Ratio	4.73	4.73	6.57	3.75	2.67	2.58
Current Ratio	4.86	4.86	6.74	3.95	2.92	2.63
Return on Equity (ROE)	8.67%	8.67%	-254.98%	-59.33%	-42.68%	-32.36%
Return on Assets (ROA)	4.87%	4.87%	-39.43%	-17.58%	-15.91%	-15.11%
Return on Capital (ROIC)	5.39%	5.39%	-43.84%	-21.89%	-23.88%	-20.31%
Return on Capital Employed (ROCE)	8.30%	8.30%	-58.00%	-31.10%	-32.30%	-26.40%
Earnings Yield	-0.02%	-0.03%	-24.90%	-7.13%	-5.03%	-2.16%
FCF Yield	1.77%	3.29%	-25.10%	-11.48%	-5.40%	2.27%
Buyback Yield / Dilution	-11.67%	-11.67%	-12.21%	-1.26%	-1.62%	-3.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.